First-line treatment in metastatic colorectal cancer: Important or crucial?

被引：5
|
作者：
Malka, David [1 ]
Rotolo, Federico [2 ,3 ]
Boige, Valerie [1 ]
机构：
[1] Univ Paris Saclay, Dept Canc Med, Gustave Roussy, Villejuif, France
[2] Univ Paris Saclay, Serv Biostat & Epidemiol, Gustave Roussy, Villejuif, France
[3] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 84卷
关键词：
PROGRESSION-FREE SURVIVAL; FOLFIRI PLUS CETUXIMAB; KRAS WILD-TYPE; EARLY TUMOR SHRINKAGE; PHASE-III; OPEN-LABEL; ACQUIRED-RESISTANCE; RANDOMIZED PHASE-3; 2ND-LINE TREATMENT; TREATMENT LINES;
D O I：
10.1016/j.ejca.2017.09.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 366
页数：4
相关论文
共 50 条
  • [41] ECONOMIC EVALUATION OF THE USE OF CAPECITABINE AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER IN MEXICO
    Lechuga, D.
    Alva, M.
    Leyva, V
    Salinas, G. E.
    VALUE IN HEALTH, 2012, 15 (04) : A222 - A223
  • [42] Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
    Xuetong Rong
    Haiyi Liu
    Hongmei Yu
    Jian Zhao
    Jie Wang
    Yusheng Wang
    Investigational New Drugs, 2022, 40 : 340 - 348
  • [43] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [44] Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
    Rong, Xuetong
    Liu, Haiyi
    Yu, Hongmei
    Zhao, Jian
    Wang, Jie
    Wang, Yusheng
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 340 - 348
  • [45] Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’
    M J Molina-Garrido
    C Guillén-Ponce
    British Journal of Cancer, 2011, 104 : 224 - 225
  • [46] Comment on 'Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'
    Molina-Garrido, M. J.
    Guillen-Ponce, C.
    BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 224 - 225
  • [47] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Axel Grothey
    Nature Clinical Practice Oncology, 2009, 6 : 10 - 11
  • [48] Bevacizumab with chemotherapy for the first-line treatment of metastatic colorectal cancer: "NCI Slovakia" results
    Dolinsky, J.
    Salek, T.
    Hlavata, Z.
    Ivancova, H.
    Risnyovszka, Z.
    Mardiak, J.
    Koza, I
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 70
  • [49] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Grothey, Axel
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (01): : 10 - 11
  • [50] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345